Mizuno K, Ikegami M, Chen C M, Ueda T, Jobe A H
Department of Pediatrics, Harbor-UCLA Medical Center, UCLA School of Medicine, Torrance 90509, USA.
Pediatr Res. 1995 Mar;37(3):271-6. doi: 10.1203/00006450-199503000-00004.
The effect of the addition of surfactant protein (SP)-B or SP-B plus SP-C (SP-BC) to a surfactant made from bovine lung (Survanta) was evaluated in 27-d-gestation preterm rabbits. The animals were treated with Survanta, Survanta + 2% SP-B, Survanta + 3% SP-BC, or sheep surfactant. They were then ventilated with 3 cm H2O positive end-expiratory pressure and tidal volumes of 8 mL/kg. Survanta + 2% SP-B was prepared by adding SP-B in water to Survanta or by adding SP-B in chloroform [SP-B(Chl)] to lipid-extracted Survanta. Dynamic compliances of the Survanta + 2% SP-B(Chl)- and Survanta + 3% SP-BC-treated rabbits were greater (p < 0.05) than those treated with Survanta or Survanta + 2% SP-B in water and were comparable to sheep surfactant. Postventilation pressure-volume curves for the groups treated with Survanta supplemented with SP-B had significantly larger retained volumes on deflation compared with those treated only with Survanta (p < 0.01). The effects of ventilation style on the responses were assessed by ventilating other groups of rabbits treated with Survanta, Survanta + 0.5% SP-B(Chl), Survanta + 2% SP-B(Chl), or sheep surfactant with tidal volumes of 10 mL/kg and 0 cm H2O positive end-expiratory pressure. SP-B (2%) augmented the in vivo function of Survanta without positive end-expiratory pressure, and 0.5% SP-B had no effect. Infasurf, a surfactant with more SP-B, was more effective than Survanta when tested in the preterm rabbits. SP-B is a critical factor for optimum immediate surfactant function.
在妊娠27天的早产兔中评估了向牛肺表面活性剂(Survanta)中添加表面活性蛋白(SP)-B或SP-B加SP-C(SP-BC)的效果。动物分别接受Survanta、Survanta + 2% SP-B、Survanta + 3% SP-BC或羊肺表面活性剂治疗。然后以3 cm H2O呼气末正压和8 mL/kg潮气量进行通气。Survanta + 2% SP-B通过将水中的SP-B添加到Survanta中或通过将氯仿中的SP-B [SP-B(Chl)]添加到脂质提取的Survanta中来制备。接受Survanta + 2% SP-B(Chl)和Survanta + 3% SP-BC治疗的兔子的动态顺应性高于接受Survanta或水中Survanta + 2% SP-B治疗的兔子(p < 0.05),且与羊肺表面活性剂相当。与仅接受Survanta治疗的组相比,接受添加SP-B的Survanta治疗的组在呼气时的压力-容积曲线显示出明显更大的残留容积(p < 0.01)。通过对其他接受Survanta、Survanta + 0.5% SP-B(Chl)、Survanta + 2% SP-B(Chl)或羊肺表面活性剂治疗的兔子以10 mL/kg潮气量和0 cm H2O呼气末正压进行通气,评估通气方式对反应的影响。2%的SP-B在无呼气末正压的情况下增强了Survanta的体内功能,而0.5%的SP-B则无作用。在早产兔中进行测试时,含有更多SP-B的Infasurf表面活性剂比Survanta更有效。SP-B是实现最佳即时表面活性剂功能的关键因素。